Coccidioidomycosis screening: Difference between revisions
Aditya Ganti (talk | contribs) |
m (Bot: Removing from Primary care) |
||
(6 intermediate revisions by 3 users not shown) | |||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}}; {{VB}}; {{ADG}} | {{CMG}}; {{AE}}; {{VB}}; {{ADG}} | ||
==Overview== | ==Overview== | ||
It is important to screen for Coccidioidomycosis in all cases of | It is important to screen for [[Coccidioidomycosis]] in all cases of [[Community-acquired pneumonia|community acquired pneumonia]] in endemic areas. | ||
==Screening== | ==Screening== | ||
Coccidioidomycosis is often mistaken for [[community acquired pneumonia]](CAP) and this grossly underestimates the actual cases in the community. It is therefore important to screen for Coccidioidomycosis in all cases of | [[Coccidioidomycosis]] is often mistaken for [[community acquired pneumonia]](CAP) and this grossly underestimates the actual cases in the community. It is therefore important to screen for [[Coccidioidomycosis]] in all cases of community acquired pneumonia in endemic areas.<ref name="Chang-2008">{{Cite journal | last1 = Chang | first1 = DC. | last2 = Anderson | first2 = S. | last3 = Wannemuehler | first3 = K. | last4 = Engelthaler | first4 = DM. | last5 = Erhart | first5 = L. | last6 = Sunenshine | first6 = RH. | last7 = Burwell | first7 = LA. | last8 = Park | first8 = BJ. | title = Testing for coccidioidomycosis among patients with community-acquired pneumonia. | journal = Emerg Infect Dis | volume = 14 | issue = 7 | pages = 1053-9 | doi = 10.3201/eid1407.070832 | PMID = 18598625 }}</ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Fungal diseases]] | [[Category:Fungal diseases]] | ||
[[Category:Biological weapons]] | [[Category:Biological weapons]] | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Emergency medicine]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] |
Latest revision as of 21:00, 29 July 2020
Coccidioidomycosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Coccidioidomycosis screening On the Web |
American Roentgen Ray Society Images of Coccidioidomycosis screening |
Risk calculators and risk factors for Coccidioidomycosis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: ; Vidit Bhargava, M.B.B.S [2]; Aditya Ganti M.B.B.S. [3]
Overview
It is important to screen for Coccidioidomycosis in all cases of community acquired pneumonia in endemic areas.
Screening
Coccidioidomycosis is often mistaken for community acquired pneumonia(CAP) and this grossly underestimates the actual cases in the community. It is therefore important to screen for Coccidioidomycosis in all cases of community acquired pneumonia in endemic areas.[1]
References
- ↑ Chang, DC.; Anderson, S.; Wannemuehler, K.; Engelthaler, DM.; Erhart, L.; Sunenshine, RH.; Burwell, LA.; Park, BJ. "Testing for coccidioidomycosis among patients with community-acquired pneumonia". Emerg Infect Dis. 14 (7): 1053–9. doi:10.3201/eid1407.070832. PMID 18598625.